A study on the potential of SARS-virus-like bat coronaviruses to cause human disease has reawakened the debate on the risks and benefits of engineering viruses. Let’s go over the science and then see if any of the criticisms have merit. Read More
This episode: Bacteria that swarm around in groups carry other bacteria with them that can be helpful for degrading toxins!
(14.2 MB, 15.5 minutes)
When the Ebola virus outbreak erupted in West Africa in 2014, children infected with the virus -- particularly those under age 5 -- faced overwhelming challenges. Not only was there a high death rate among young children infected with the disease, they often were isolated from their families, le... Read More
New results from a study performed at the University of Helsinki suggest that genomic information from circulating influenza viruses can help in producing more efficient seasonal vaccines. The researchers were able to develop a simple approach for reliable real-time tracking and prediction of vi... Read More
A team of Massachusetts General Hospital (MGH) investigators has shown that a method they developed to improve the usefulness and precision of the most common form of the gene-editing tools CRISPR-Cas9 RNA-guided nucleases can be applied to Cas9 enzymes from other bacterial sources. In a paper r... Read More
Insecticide-treated nets may still help prevent malaria despite mosquitoes developing resistance, according to a new study published in Parasites & Vectors. Read More
This episode: Bacterial spores can survive atmospheric entry on an artificial meteorite!
(10.7 MB, 11.25 minutes)
This holiday season, as you open a bottle of your favorite wine to share with family and friends, consider making a toast to Saccharomyces cerevisiae (also known as “brewer’s yeast”) which is a species of yeast that is commonly used for making wine and beer. Yeast is absolutely essential to wine... Read More
Recent developments in surveillance technology could enable a swifter, more effective response to potentially deadly outbreaks of disease, a study has found. Read More
The microbiome of hibernating bears, and zebrafish as a model for bacterial sepsis feature in this animal-centric episode of TWiM hosted by Vincent, Michael, and Michele.
Image: Bright-field (top) and fluorescent (bottom) images of zebrafish embryos infected with E. coli strain F11. E... Read More
Scientists have identified a gene that could potentially open the door for the development of new treatments of the lethal disease sepsis. Read More
Mysterious fungus killing snakes in NY, at least 8 other states | wivb.com - http://wivb.com/2015/08/10/mysterious-fungus-killing-snakes-in-ny-at-least-8... Read More
In a novel use of the CRISPR/Cas9 system, which can be deployed to switch genes off, researchers from Germany, the UK and Spain have developed a multiplexed screening approach to study and model cancer development in mice. The scientists mutated genes in the adult mouse liver uncovering their ca... Read More
A gene that lets bacteria resist polymyxins—the last line of antibiotic defense we have left—has shown up in widespread bacteria samples from pigs and patients in south China, including strains with epidemic potential. Read More
BOC Sciences-Latest study on vitamin C shows that it can play a positive role in improving blood vessel constriction with almost equal effect as walking. In the study, the exercise of a protein which is the main factor of blood vessel constriction was compared with the effect of vitamin C on bl... Read More
Methylobacterium aquaticum strain NO00 (KR920749) grown over rice grain. It can produce phytohormones and other beneficial metabolites for the plant. M. aquaticum is a plant growth promoting (PGP) bacteria". Its pink-biofilm, can help with water-stress and protect the plant against pathogens. Read More
Immune cells that hang around after parasitic skin infection help ward off secondary attack, according to a study in The Journal of Experimental Medicine. These skin squatters may prove to be the key to successful anti-parasite vaccines. Read More
BOC Sciences-Varubi also named as rolapitant, gained approval from FDA. And it’s said the drug went into its third phase clinical trial. Till now about 2800 patients have involved in the trial. Read More